Remember to claim your CPD when you have finished this resource.
Across clinical settings, pruritus (or itch) challenges care outcomes, can be hard to treat, and impacts on quality of life, mental health and mortality.
Pruritus can be defined as an unpleasant sensation that evokes the feeling of wanting to scratch. The reason we itch is to protect the skin against noxious stimuli, as scratching or rubbing disrupts the irritant (Chen & Sun 2020).
However, too much scratching can inflame the skin and sometimes, the cause of pruritus is not an external stimulus at all.
Accompanying many dermatologic conditions due to peripheral stimuli, pruritus also arises from systemic disease (renal, hepatic, endocrine), malignancy and medicines – all of which may present as skin disorders, but actually originate in the central nervous system (Oakley 2016; Chan 2014). Pruritus without obvious primary skin lesions should be investigated for an underlying cause.
Whatever the origins of pruritus, scratching further inflames the skin and stimulates nerve fibres, initiating the itch-scratch cycle (Fresh Air 2014). As the patient scratches, they damage their skin, leading to the release of inflammatory chemicals that increase the itchy sensation. The itch-scratch cycle alters the structure of the skin by compromising the barrier effect, may can then result in prurigo nodularis or lichenification (Yosipovitch & Hundley 2004). As such, assessing and treating itch as early as possible is an important facet of effective patient care.
Assessment of Pruritus
When assessing pruritus, the following categories will help identify what the underlying cause might be:
Dermatologic – an itch associated with skin conditions.
Systemic – driven by organs other than skin (e.g. uremia, cholestasis).
Neurogenic/Neuropathic – related to the central and peripheral nervous systems, nerve compression or nerve irritation.
Psychogenic – no dermatologic cause with a psychological component.
(Fazio & Yosipovitch 2019)
Varied causes suggest multiple mechanisms may induce pruritus. Sensory nerve endings in the epidermis and dermal-epidermal junction are stimulated by chemical mediators such as histamine, opioids, serotonin and prostaglandins. Signals are transmitted along unmyelinated, histamine-sensitive and insensitive peripheral C-nerve fibres (as opposed to C-nerve fibres that transmit pain), which causes the sensation of an itch.
Pruritus characteristics will provide clues to the origin and will indicate the most effective treatment options:
Is the itch acute? I.e. something triggers it and a ‘scratch’ usually relieves it.
Or is it chronic? I.e. present for more than six weeks and not relieved by scratching.
Is it a rash that is itchy or an itch without a rash?
Is the itch localised or generalised? Generalised and severe pruritus demands evaluation for systemic disease, which will mean blood tests, physical examination and possibly imaging.
Determining the underlying cause of pruritus and individualising treatment will require a nursing assessment, which should include a full history as well as a skin examination.
When performing a skin examination ensure that you use adequate lighting to inspect the skin texture and any subtle lesions that may be present. Pay attention to affected and non-affected skin, including web spaces and skin folds. Primary lesions that are unaltered by scratching may indicate a dermatological cause while secondary lesions only (e.g. excoriations) may suggest a systemic cause (Reamy, Bunt & Fletcher 2011). Make a note of lesion distribution and contributing conditions, such as dry skin.
When taking the patient’s history, the ‘OLD CARTS’ mnemonic formula will help to guide and order your collection of information:
Onset – when did it start?
Location – localised or generalised? Initial location, progression, distribution (some aetiologies display pruritus in favoured sites)?
Duration – acute or chronic?
Character – stinging or burning?
Aggravating factors – environmental, treatments prescribed or over-the-counter medicine?
Relieving factors – environmental, treatments prescribed or over-the-counter medicine?
Timing – is the itch consistently present or does it come and go? Is it seasonal or related to the time of day? Has it been experienced previously? Are there circumstances surrounding appearance such as illness, travel or contacts?
Severity – is it so severe that it disrupts sleep?
(Van Onselen 2016)
Be sure to add a detailed medication history, including over the counter medicines, natural remedies, new prescription medicines and current medicines where the dose has been altered.
Treatment of Pruritis
The first line of management for mild, localised pruritus is topical therapies. Systemic strategies are added depending on severity and extent (Patel & Yosipovitch 2010). These should be employed in conjunction with the removal of aggrevating external factors, for example:
Encouraging cooler, shorter showers;
Moisturising immediately after bathing in order to improve barrier function and maintain the acid mantle;
Using fragrence-free soap products to reduce skin irritation;
Wearing loose-fitting clothes and avoiding rough fabrics such as wool;
Using cool compresses to relieve heat and assist with hydration of the skin;
Maintaining a cool, neutral-humidity environment and avoiding extreme temperature changes;
Using a humidifier during winter;
Cutting fingernails or wearing gloves at night to avoid further scratching; and
Sleeping in a cooler environment to avoid overheating.
(AAD 2020; Healthdirect 2019)
Applying wet dressings with moisturiser can be soothing, but caution must be applied in older people and people with infected skin.
Additional measures that might be applied depending on the underlying cause include:
Topical antipruritics such as menthol or oatmeal;
Oral antihistamines, although consider the sedating effect;
Topical corticosteroids; and
Phototherapy with a dermatologist’s referral.
Pruritus commonly causes physical and psychological distress. Individual evaluation with considered methodical care and management will help to aid this complex issue and provide much needed relief to your patient.
Jan Riley is a specialist dermatology nurse based in regional New South Wales, Australia. Her postgraduate studies include a Certificate in Dermatology Nursing (USA), Master of Nursing (NP) and Certificates in Dermoscopy and Skin Cancer Medicine. Driven by a passion for “all things skin”, Jan is a staunch and passionate mentor and advocate, who is always ready and willing to share knowledge and inspire nurses to understand skin’s impact on daily lives. Her active participation in a range of professional activities has greatly assisted to raise the profile of dermatology and skin disease in the community. Jan currently develops and presents skin education modules through a co-directed nurse education company (Dermatology Nurse Education Australia) for nurses across all areas of care delivery. See Educator Profile